FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2943802261> ?p ?o ?g. }

• W2943802261 endingPage "6923" @default.
• W2943802261 startingPage "6907" @default.
• W2943802261 abstract "Nano-TiO 2 and nano-CeO 2 are among the most widely used engineered nanoparticles (NPs). We investigated a variety of endpoints to assess the toxicity of eight of these NPs to induce potentially adverse health effects in an In Vitro human respiratory epithelial cell model. These endpoints include cytotoxicity, reactive oxygen species (ROS)/reactive nitrogen species (RNS) production, 8-hydroxy-2_-deoxyguanosine (8-oxo-dG), endogenous DNA adducts, Apurinic/apyrimidinic (AP) sites, 4-Hrdoxynonenal (4-HNE) protein adducts, Malondialdehyde (MDA) protein adducts, and genomics analysis on altered signaling pathways. Our results indicated that cytotoxicity assays are relatively insensitive, and we detected changes in other endpoints at concentrations much lower than those inducing cytotoxicity. Among the ROS-related endpoints, 8-oxo-dG is relatively more sensitive than other assays, and nano-TiO 2 induced more 8-oxo-dG formation than nano-CeO 2 . Finally, there are many signaling pathways changes at concentrations at which no cytotoxicity was observed. These alterations in signaling pathways correlated well with In Vitro toxicity that was observed at higher concentrations, and with in vivo adverse outcome pathways caused by nano-TiO 2 and nano-CeO 2 in experimental animals." @default.
• W2943802261 created "2019-05-09" @default.
• W2943802261 creator A5016841691 @default.
• W2943802261 creator A5029127133 @default.
• W2943802261 creator A5044870922 @default.
• W2943802261 creator A5051213132 @default.
• W2943802261 creator A5055052895 @default.
• W2943802261 creator A5057421354 @default.
• W2943802261 creator A5063606524 @default.
• W2943802261 creator A5080154408 @default.
• W2943802261 creator A5083518321 @default.
• W2943802261 date "2019-11-01" @default.
• W2943802261 modified "2023-10-14" @default.
• W2943802261 title "Differential Effects of Nano TiO₂ and CeO₂ on Normal Human Lung Epithelial Cells <i>In Vitro</i>" @default.
• W2943802261 cites W1965037124 @default.
• W2943802261 cites W1968842483 @default.
• W2943802261 cites W1969040530 @default.
• W2943802261 cites W1974089896 @default.
• W2943802261 cites W1985133515 @default.
• W2943802261 cites W1986440776 @default.
• W2943802261 cites W1987741979 @default.
• W2943802261 cites W1990227631 @default.
• W2943802261 cites W2000463136 @default.
• W2943802261 cites W2003651291 @default.
• W2943802261 cites W2005153037 @default.
• W2943802261 cites W2005883236 @default.
• W2943802261 cites W2006451106 @default.
• W2943802261 cites W2014144915 @default.
• W2943802261 cites W2017300339 @default.
• W2943802261 cites W2025016445 @default.
• W2943802261 cites W2026124261 @default.
• W2943802261 cites W2044059472 @default.
• W2943802261 cites W2044708698 @default.
• W2943802261 cites W2044899507 @default.
• W2943802261 cites W2045142779 @default.
• W2943802261 cites W2057631086 @default.
• W2943802261 cites W2060830074 @default.
• W2943802261 cites W2061149209 @default.
• W2943802261 cites W2071562164 @default.
• W2943802261 cites W2072337529 @default.
• W2943802261 cites W2072535567 @default.
• W2943802261 cites W2082633239 @default.
• W2943802261 cites W2087074645 @default.
• W2943802261 cites W2088056775 @default.
• W2943802261 cites W2088670364 @default.
• W2943802261 cites W2110421598 @default.
• W2943802261 cites W2112100064 @default.
• W2943802261 cites W2116384075 @default.
• W2943802261 cites W2117326659 @default.
• W2943802261 cites W2123759534 @default.
• W2943802261 cites W2128838829 @default.
• W2943802261 cites W2130284298 @default.
• W2943802261 cites W2132915215 @default.
• W2943802261 cites W2135980592 @default.
• W2943802261 cites W2145429629 @default.
• W2943802261 cites W2145936343 @default.
• W2943802261 cites W2155073279 @default.
• W2943802261 cites W2157489799 @default.
• W2943802261 cites W2171794588 @default.
• W2943802261 cites W2275422414 @default.
• W2943802261 cites W2305240766 @default.
• W2943802261 cites W2316660322 @default.
• W2943802261 cites W2460520397 @default.
• W2943802261 cites W2464651354 @default.
• W2943802261 cites W2552483231 @default.
• W2943802261 cites W4229504087 @default.
• W2943802261 cites W4301166779 @default.
• W2943802261 doi "https://doi.org/10.1166/jnn.2019.16737" @default.
• W2943802261 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6690050" @default.
• W2943802261 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31039842" @default.
• W2943802261 hasPublicationYear "2019" @default.
• W2943802261 type Work @default.
• W2943802261 sameAs 2943802261 @default.
• W2943802261 citedByCount "7" @default.
• W2943802261 countsByYear W29438022612020 @default.
• W2943802261 countsByYear W29438022612021 @default.
• W2943802261 countsByYear W29438022612022 @default.
• W2943802261 countsByYear W29438022612023 @default.
• W2943802261 crossrefType "journal-article" @default.
• W2943802261 hasAuthorship W2943802261A5016841691 @default.
• W2943802261 hasAuthorship W2943802261A5029127133 @default.
• W2943802261 hasAuthorship W2943802261A5044870922 @default.
• W2943802261 hasAuthorship W2943802261A5051213132 @default.
• W2943802261 hasAuthorship W2943802261A5055052895 @default.
• W2943802261 hasAuthorship W2943802261A5057421354 @default.
• W2943802261 hasAuthorship W2943802261A5063606524 @default.
• W2943802261 hasAuthorship W2943802261A5080154408 @default.
• W2943802261 hasAuthorship W2943802261A5083518321 @default.
• W2943802261 hasBestOaLocation W29438022612 @default.
• W2943802261 hasConcept C109316439 @default.
• W2943802261 hasConcept C127445965 @default.
• W2943802261 hasConcept C143425029 @default.
• W2943802261 hasConcept C153911025 @default.
• W2943802261 hasConcept C178790620 @default.
• W2943802261 hasConcept C185592680 @default.
• W2943802261 hasConcept C202751555 @default.
• W2943802261 hasConcept C207001950 @default.
• W2943802261 hasConcept C2776151105 @default.

• next